Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels

Behavioural Brain Research

Volumn 242, Issue 1, 2013, Pages 76-83

  Walker, Adam J ^a   Burnett, Sandy A ^a   Hasebe, Kyoko ^a   McGillivray, Jane A ^a   Gray, Laura J ^a   McGee, Sean L ^a   Walder, Ken ^a   Berk, Michael ^a,b   Tye, Susannah J ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ACTH; Adrenocorticotrophic hormone; Animal model; Corticosterone; FST; HPA; Monoamine; OFT; PFC; TRD; Treatment resistant depression

Indexed keywords

ADRENALIN; CORTICOSTERONE; GLUCOCORTICOID; IMIPRAMINE; MONOAMINE; NORADRENALIN; SEROTONIN; SODIUM CHLORIDE; TETRACOSACTIDE;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOWN REGULATION; DRUG ANTAGONISM; FORCED SWIMMING TEST; LONG TERM EXPOSURE; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TISSUE LEVEL;

ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOGENIC MONOAMINES; CORTICOSTERONE; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; FREEZING REACTION, CATALEPTIC; GROOMING; IMIPRAMINE; MALE; PEPTIDE FRAGMENTS; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; SWIMMING; TIME FACTORS;

EID: 84872405175     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.12.033     Document Type: Article

References (37)

1. Stetler C., Miller G.E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosomatic Medicine 2011, 73:114-126.
2. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry 2006, 163:28-40.
3. Uher R., Dernovsek M.Z., Mors O., Hauser J., Souery D., Zobel A., et al. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. Journal of Affective Disorders 2011, 132:112-120.
4. Mathew S.J. Treatment-resistant depression: recent developments and future directions. Depression & Anxiety 2008, 25:989-992.
5. Nemeroff C.B. Prevalence and management of treatment-resistant depression. Journal of Clinical Psychiatry 2007, 68(Suppl. 8):17-25.
6. Ruhe H.G., Mason N.S., Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Molecular Psychiatry 2007, 12:331-359.
7. Kitamura Y., Araki H., Gomita Y. Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test. Pharmacology Biochemistry and Behavior 2002, 71:63-69.
8. Carroll B.J., Cassidy F., Naftolowitz D., Tatham N.E., Wilson W.H., Iranmanesh A., et al. Pathophysiology of hypercortisolism in depression. Acta Psychiatrica Scandinavica. Supplementum 2007, 433:90-103.
9. Juruena M.F., Pariante C.M., Papadopoulos A.S., Poon L., Lightman S., Cleare A.J. Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance. British Journal of Psychiatry 2009, 194:342-349.
10. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nature Neuroscience 2010, 13:1161-1169.
11. V Castagne. Rodent models of depression: Forced swim and tail suspension behavioural despair tests in rats and mice; 2009.
12. Cryan J.F., Page M.E., Lucki I. Differential behavioural effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology 2005, 182:335-344.
13. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
14. Jain R. Single-action versus dual-action antidepressants. The Primary Care Companion to The Journal of Clinical Psychiatry 2004, 6:7-11.
15. Richelson E. Pharmacology of antidepressants. Mayo Clinic Proceedings 2001, 76:511-527.
16. NR Carlson. Physiology of Behavior; 2007.
17. Hindmarch I. Beyond the monoamine hypothesis: mechanisms, molecules and methods. European Psychiatry 2002, 17(Suppl. 3):294-299.
18. Musazzi L., Racagni G., Popoli M. Stress, glucocorticoids and glutamate release: effects of antidepressant drugs. Neurochemistry International 2011, 59:138-149.
19. Belda X., Armario A. Dopamine D1 and D2 dopamine receptors regulate immobilization stress-induced activation of the hypothalamus-pituitary-adrenal axis. Psychopharmacology 2009, 206:355-365.
20. Andrews P., Kornstein S., Halberstadt L., Gardner C., Neale M.C. Blue again: Perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Frontiers in Psychology 2011, 2.
21. Pariante C.M. Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Annals of the New York Academy of Sciences 2009, 1179:144-152.
22. Carroll B.J., Cassidy F., Naftolowitz D., Tatham N.E., Wilson W.H., Iranmanesh A., et al. Pathophysiology of hypercortisolism in depression. Acta Physiologica Scandinavica. Supplementum 2007, 9:0-103.
23. Piras G., Giorgi O., Corda M.G. Effects of antidepressants on the performance in the forced swim test of two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions. Psychopharmacology 2010, 211:403-414.
24. Cryan J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neuroscience & Biobehavioral Reviews 2005, 29:547-569.
25. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
26. Cryns K., Shamir A., Shapiro J., Daneels G., Goris I., Van Craenendonck H., et al. Lack of lithium-like behavioral and molecular effects in IMPA2 knockout mice. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2007, 32:881-891.
27. Connor T.J., Kelly J.P., Leonard B.E. Forced swim test-induced neurochemical, endocrine, and immune changes in the rat. Pharmacology Biochemistry and Behavior 1997, 58:961-967.
28. Stahl S.M., Wise D.D. The potential role of a corticotropin-releasing factor receptor-1 antagonist in psychiatric disorders. CNS Spectrums 2008, 13:467-483.
29. Berk M., Dodd S., Kauer-Sant'Anna M., Malhi G.S., Bourin M., Kapczinski F., et al. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatrica Scandinavica 2007, 116:41-49.
30. Basso A.M., Gallagher K.B., Bratcher N.A., Brioni J.D., Moreland R.B., Hsieh G.C., et al. Antidepressant-like effects of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test. Neuropsychopharmacology 2005, 30:1257-1268.
31. Cabib S., Puglisi-Allegra S. The mesoaccumbens dopamine in coping with stress. Neuroscience & Biobehavioral Reviews 2012, 36:79-89.
32. D'Aquila P.S. Dopamine on D2-like receptors reboosts dopamine D1-like receptor-mediated behavioural activation in rats licking for sucrose. Neuropharmacology 2010, 58:1085-1096.
33. D'Aquila P.S., Galistu A. Possible role of dopamine D1-like and D2-like receptors in behavioural activation and evaluation of response efficacy in the forced swimming test. Neuropharmacology 2012, 62:1717-1729.
34. Perona M.T.G., Waters S., Hall F.S., Sora I., Lesch K-P., Murphy D.L., et al. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behavioural Pharmacology 2008, 19:566-574.
35. Mora F, Segoviaa G, del Arcoa A, de Blasa M, Garridoa P. Stress, neurotransmitters, corticosterone and body-brain integration, 2012.
36. Cabib S., Ventura R., Puglisi-Allegra S. Opposite imbalances between mesocortical and mesoaccumbens dopamine responses to stress by the same genotype depending on living conditions. Behavioural Brain Research 2002, 129:179-185.
37. Kitamura Y., Yagi T., Kitagawa K., Shinomiya K., Kawasaki H., Asanuma M., et al. Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats. Naunyn Schmiedebergs Archives of Pharmacology 2010, 382:151-158.